Selective killing of oncogenic human cells cocultivated with normal human fibroblasts.
Histidinol and theophylline reversibly arrested the growth of low-passage human foreskin fibroblasts (HFF) and protected these cells from an otherwise lethal combination of the S-phase drugs beta-cytosine arabinoside and hydroxyurea. In contrast, HeLa cells continued cell cycle transit in the presence of histidinol and theophylline. Consequently, these reagents did not after the vulnerability of HeLa cells to combined S-phase drugs. The differential S-phase drug sensitivity mediated by histidinol and theophylline persisted under cocultivation conditions, thereby allowing the selective and total eradiction of colonies of HeLa cells in the presence of subconfluent HFF cells. The HFF cells, spared S-phase drug toxicity by their unique response to histidinol and theophylline, showed total survival and viability.[1]References
- Selective killing of oncogenic human cells cocultivated with normal human fibroblasts. Warrington, R.C. J. Natl. Cancer Inst. (1978) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
